This item is not eligible for Amazon Prime, but millions of other items are. Join Amazon Prime today. Already a member? Sign in.


Digital Delivery
(How does this work?)
 

Amgen and Biovitrum sign metobolic disease license agreement.: An article from: BIOTECH Patent News
  

Amgen and Biovitrum sign metobolic disease license agreement.: An article from: BIOTECH Patent News [HTML] (Digital)

No customer reviews yet. Be the first.

List Price: $5.95
Price: $5.95
Available for download now.
Ships from and sold by Amazon.com.

Edition: e-document (Learn more)
Good Books Make Great Gifts
Save all season long on bestsellers, kids' books, holiday favorites and more in our Books Holiday Store.

Editorial Reviews

Product Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on September 1, 2003. The length of the article is 634 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Amgen and Biovitrum sign metobolic disease license agreement.
Publication: BIOTECH Patent News (Newsletter)
Date: September 1, 2003
Publisher: Biotech Patent News
Volume: 17 Issue: 9

Distributed by Thomson Gale

Product Details

  • Format: HTML
  • Printable: Yes
  • Mac OS Compatible: Yes
  • Windows Compatible: Yes
  • Handheld Compatible: Yes
  • File Size: 5 KB
  • Publisher: Biotech Patent News (July 31, 2005)
  • Average Customer Review: No customer reviews yet. Be the first.
  • Required Free Software: Any web browser

Rate This Item to Improve Your Recommendations

I own it Not rated Your rating
Don't like it < > I love it!
Save your
rating
  
?

1

2

3

4

5

Customer Reviews


There are no customer reviews yet.   Create your own review
Video reviews
Video reviews
New feature! Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.